Strata Skin Sciences, Inc. (NASDAQ:SSKN) is set to issue its quarterly earnings data after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter.

Strata Skin Sciences (NASDAQ:SSKN) last announced its earnings results on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, topping the consensus estimate of ($0.71) by $0.19. The company had revenue of $8.70 million for the quarter, compared to analysts’ expectations of $7.98 million. Strata Skin Sciences had a negative return on equity of 41.58% and a negative net margin of 18.00%. On average, analysts expect Strata Skin Sciences to post $-3.14 EPS for the current fiscal year and $-0.77 EPS for the next fiscal year.

Shares of Strata Skin Sciences, Inc. (NASDAQ SSKN) opened at 1.28 on Wednesday. Strata Skin Sciences, Inc. has a one year low of $1.10 and a one year high of $5.40. The stock’s 50 day moving average price is $1.67 and its 200 day moving average price is $2.16. The company’s market cap is $3.17 million.

TRADEMARK VIOLATION WARNING: “Strata Skin Sciences, Inc. (SSKN) Scheduled to Post Quarterly Earnings on Wednesday” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.americanbankingnews.com/2017/11/01/strata-skin-sciences-inc-sskn-scheduled-to-post-quarterly-earnings-on-wednesday.html.

Several equities analysts have recently issued reports on SSKN shares. ValuEngine upgraded Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st. HC Wainwright set a $12.00 price target on Strata Skin Sciences and gave the company a “buy” rating in a research note on Friday, August 11th. Finally, Zacks Investment Research lowered Strata Skin Sciences from a “hold” rating to a “sell” rating in a research note on Wednesday, August 16th.

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Earnings History for Strata Skin Sciences (NASDAQ:SSKN)

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.